Synoste Ltd, a Helsinki, Finland-based medical device company, raised €5.1m in funding.
The round was led by Lifeline Ventures and AO Invest.
Led by Managing Director and co-founder Harri Hallila, Synoste has created smart solutions for patient-friendly bone-lengthening and bone-deformation correction. The company, also located in Düsseldorf, Germany, has developed a patented technology platform that provides the basis for innovation in the treatment of congenital, trauma- and tumour-related limb discrepancies, adult and paediatric deformities, and craniomaxillofacial deformations.
The company intends to use the funds to start clinical investigations and to develop new clinical applications.
This round brought total funding raised to date by the company to €10m. Other investors in Synoste include:
– Evonik Venture Capital,
– High-Tech Gründerfonds,
– Innovestor Ventures, and
– Mectalent.
FinSMEs
18/10/2018